About Growth/differentiation factor 2
Growth/differentiation factor 2 (GDF2) is a protein
from Homo sapiens identified by UniProt accession
Q9UK05, 429 residues long.
MolForge cross-references it against 0 known binders and
233 disease associations.
Target properties
| Protein name | Growth/differentiation factor 2 |
| UniProt accession | Q9UK05 |
| Gene | GDF2 |
| Organism | Homo sapiens |
| Length | 429 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (233)
Diseases linked to this target (Open Targets).
- hereditary hemorrhagic telangiectasia · score 0.71
- heritable pulmonary arterial hypertension · score 0.56
- pulmonary arterial hypertension · score 0.46
- erythrocyte count · score 0.28
- colorectal neoplasm · score 0.26
- hemoglobin measurement · score 0.26
- hematocrit · score 0.26
- systolic blood pressure · score 0.23
- red blood cell density measurement · score 0.20
- Abnormality of the cardiovascular system · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UK05-F1 | alphafold | PREDICTED | 74.61 | — |
Amino-acid sequence (429 residues)
MCPGALWVAL PLLSLLAGSL QGKPLQSWGR GSAGGNAHSP LGVPGGGLPE HTFNLKMFLE NVKVDFLRSL NLSGVPSQDK TRVEPPQYMI DLYNRYTSDK STTPASNIVR SFSMEDAISI TATEDFPFQK HILLFNISIP RHEQITRAEL RLYVSCQNHV DPSHDLKGSV VIYDVLDGTD AWDSATETKT FLVSQDIQDE GWETLEVSSA VKRWVRSDST KSKNKLEVTV ESHRKGCDTL DISVPPGSRN LPFFVVFSND HSSGTKETRL ELREMISHEQ ESVLKKLSKD GSTEAGESSH EEDTDGHVAA GSTLARRKRS AGAGSHCQKT SLRVNFEDIG WDSWIIAPKE YEAYECKGGC FFPLADDVTP TKHAIVQTLV HLKFPTKVGK ACCVPTKLSP ISVLYKDDMG VPTLKYHYEG MSVAECGCR
Explore Growth/differentiation factor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets